RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Moors & Cabot, Inc.'s Holding History (CIK: 0001607239)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 27,750 Value ($000) $113 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 28,646 Value ($000) $140 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 44,550 Value ($000) $225 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 43,870 Value ($000) $232 Avg Close $7.29 Range $5.19 - $12.36

Q1 2024

Shares 13,500 Value ($000) $135 Avg Close $11.14 Range $8.68 - $15.74

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	27,750	$113	$4.95	$3.81 - $7.18
Q3 2025	28,646	$140	$5.25	$4.45 - $7.15
Q2 2025	44,550	$225	$4.91	$3.79 - $6.11
Q1 2025	43,870	$232	$7.29	$5.19 - $12.36
Q1 2024	13,500	$135	$11.14	$8.68 - $15.74